Terms: = Uterine cancer AND CEACAM5, CEA
465 results:
1. Cervical clear cell carcinoma: Case report and literature review.
Su D; Song X; Wu F; Fan S; Li M
Medicine (Baltimore); 2024 Mar; 103(13):e37449. PubMed ID: 38552088
[TBL] [Abstract] [Full Text] [Related]
2. Tumor and metastatic lymph nodes metabolic activity on
Song J; Pang W; Yi H; Ji J; Ye X; Li L
Abdom Radiol (NY); 2024 Mar; 49(3):975-984. PubMed ID: 38302763
[TBL] [Abstract] [Full Text] [Related]
3. Identifying tumor markers-stratified subtypes (CA-125/CA19-9/carcinoembryonic antigen) in cervical adenocarcinoma.
Zhang Z; Li Y; Wu Y; Bi R; Wu X; Ke G; Zhu J
Int J Biol Markers; 2023 Dec; 38(3-4):223-232. PubMed ID: 37933442
[TBL] [Abstract] [Full Text] [Related]
4. Meta-analysis of the efficacy and safety of Xihuang Pills/capsules in adjuvant treatment of uterine cervical neoplasms.
Xu H; Tian G; Wu C; Sun X; Li K
Medicine (Baltimore); 2023 Aug; 102(34):e34846. PubMed ID: 37653807
[TBL] [Abstract] [Full Text] [Related]
5. Effectiveness of Clinic-Based Patient-Led Human Papillomavirus DNA Self-Sampling among HIV-Infected Women in Uganda.
Nyabigambo A; Mayega RW; Ginindza TG
Int J Environ Res Public Health; 2023 Aug; 20(16):. PubMed ID: 37623195
[TBL] [Abstract] [Full Text] [Related]
6. MLK4 as an immune marker and its correlation with immune infiltration in Cervical squamous cell carcinoma and endocervical adenocarcinoma(CESC).
Gong M; Shen F; Li Y; Ming L; Hong L
PLoS One; 2023; 18(8):e0290462. PubMed ID: 37594950
[TBL] [Abstract] [Full Text] [Related]
7. Fine-grained mathematical modeling for cost-effectiveness evaluation of public health policies for cervical cancer, with application to a Colombian case study.
Angulo D; Cortes MF; Mura I; Akhavan-Tabatabaei R
BMC Public Health; 2023 Aug; 23(1):1470. PubMed ID: 37533028
[TBL] [Abstract] [Full Text] [Related]
8. Pretreatment carcinoembryonic antigen combined with cancer antigen-125 for predicting lymph node metastasis in endometrial carcinoma: a retrospective cohort study.
Huang SY; Fu HC; Wu CH; Wang SC; Ou YC; Tsai CC; Chen YY; Huang SW; Wang YW; Lin H
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11807-11813. PubMed ID: 37405474
[TBL] [Abstract] [Full Text] [Related]
9. Ovarian seromucinous carcinoma: an independent epithelial ovarian cancer?
Hu Y; Fu K; Liu H; He Q; Qiu X; Yang W; Zhang Y
J Ovarian Res; 2023 Jan; 16(1):18. PubMed ID: 36670456
[TBL] [Abstract] [Full Text] [Related]
10. It is more than uterine fibroids: Incidental discovery of adenoma malignum of the cervix.
Abada E
Malays J Pathol; 2022 Dec; 44(3):533-538. PubMed ID: 36591722
[TBL] [Abstract] [Full Text] [Related]
11. Evaluation of HE4 as a prognostic biomarker in uterine cervical cancer
Dubey H; Ranjan A; Durai J; Khan MA; Lakshmy R; Khurana S; Gupta S; Meena J; Ray MD; Tanwar P; Chopra A; Tiwari S
Cancer Treat Res Commun; 2023; 34():100672. PubMed ID: 36525756
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathologic Features and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas.
Ok Atılgan A; Özen Ö; Haberal Reyhan AN; Ayhan A
Int J Surg Pathol; 2023 Jun; 31(4):398-408. PubMed ID: 36452965
[TBL] [Abstract] [Full Text] [Related]
13. Changes of T Lymphocyte Subsets in Peripheral Blood of Patients with Intermediate and Advanced Cervical cancer before and after Nimotuzumab Combined with Chemoradiotherapy.
Teng F; Cui G; Qian L; Zhao L
Int Arch Allergy Immunol; 2023; 184(1):85-97. PubMed ID: 36265457
[TBL] [Abstract] [Full Text] [Related]
14. Human papillomavirus integration perspective in small cell cervical carcinoma.
Wang X; Jia W; Wang M; Liu J; Zhou X; Liang Z; Zhang Q; Long S; Quzhen S; Li X; Tian Q; Li X; Sun H; Zhao C; Meng S; Ning R; Xi L; Wang L; Zhou S; Zhang J; Wu L; Chen Y; Liu A; Ma Y; Zhao X; Cheng X; Zhang Q; Han X; Pan H; Zhang Y; Cao L; Wang Y; Ling S; Cao L; Xing H; Xu C; Sui L; Wang S; Zhou J; Kong B; Xie X; Chen G; Li S; Ma D; Li S
Nat Commun; 2022 Oct; 13(1):5968. PubMed ID: 36216793
[TBL] [Abstract] [Full Text] [Related]
15. Laparoscopic Radical Hysterectomy Combined with Neoadjuvant Chemotherapy for Cervical cancer Patients Effectively Improves Immune Function.
Liu M; Wang H; Du S; Li W; Xuan F; Zhao Y; Li N
Dis Markers; 2022; 2022():3611174. PubMed ID: 36157208
[TBL] [Abstract] [Full Text] [Related]
16. [Metastasis of medullary thyroid carcinoma to the endometrium: A case report and review of the literature].
García Kamermann FA; Falcon MF; Monges YM; Diaz LB; Cardinal LH
Rev Esp Patol; 2022; 55(4):245-248. PubMed ID: 36154731
[TBL] [Abstract] [Full Text] [Related]
17. A microfluidic chip using Au@SiO
Gu Y; Li Z; Ge S; Mao Y; Gu Y; Cao X; Lu D
Anal Bioanal Chem; 2022 Nov; 414(26):7659-7673. PubMed ID: 36050486
[TBL] [Abstract] [Full Text] [Related]
18. Membranous and nuclear staining of CLDN18 in HPV-independent and HPV-associated endocervical adenocarcinomas.
Du X; Hu Y; Ji X; Sui L; Zheng Q; Song K; Lv T; Chen Y; Zhao H; Dai S; Zhao P; Yao Q
Cancer Med; 2023 Jan; 12(2):1441-1450. PubMed ID: 35861118
[TBL] [Abstract] [Full Text] [Related]
19. Efficacy and Side Effects of Irinotecan Combined with Nedaplatin versus Paclitaxel Combined with Cisplatin in Neoadjuvant Chemotherapy for Locally Advanced Cervical cancer and Tumor Marker Analysis: Based on a Retrospective Analysis.
Jiang Y; Song B; Chen Z
Comput Math Methods Med; 2022; 2022():5936773. PubMed ID: 35693259
[TBL] [Abstract] [Full Text] [Related]
20. Frequency and impact of the inclusion of broader measures of value in economic evaluations of vaccines.
Silver MC; Neumann PJ; Ma S; Kim DD; Cohen JT; Nyaku M; Roberts C; Sinha A; Ollendorf DA
Vaccine; 2021 Nov; 39(46):6727-6734. PubMed ID: 34656380
[TBL] [Abstract] [Full Text] [Related]
[Next]
